Search

everythinglearnresearchcommunity

for

Search:↓

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Vitamin C was found to effectively treat prickly heat in children.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Calcium pantothenate therapy improved symptoms of discoid lupus erythematosus without side effects.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

ATP helps prevent skin damage from vandetanib by reducing stress.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Cepharanthine shows promise as a COVID-19 treatment.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.